Juniper Research’s complimentary whitepaper, Are Digital Therapeutics Poison or Tonic for Drug Companies?, examines the potential that digital therapeutics have to either reshape or complement the existing healthcare ecosystem, as well as providing a forecast for digital therapeutics revenues in 2023.
- Digital Therapeutics Development
- Digital Therapeutics & the Future of Medicine
- Digital Therapeutics Forecast
- Order the Full Research